Aurinia Pharmaceuticals Inc.
AUPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600620
In the last 90 days, Aurinia Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 282 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Aurinia Pharmaceuticals Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 192
- +5 vs. Q3 2022
- Shares held
- 51.6M
- −4.27M (−7.6%) vs. Q3 2022
- Total value
- $223.1M
- −$197.1M (−46.9%) vs. Q3 2022
- New holders
- 35
- 55 more added
- Sold out
- 30
- 48 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AUPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 282 | $1.34B |
| Q1 2026 | 260 | $1.10B |
| Q4 2025 | 256 | $1.15B |
| Q3 2025 | 242 | $729.8M |
| Q2 2025 | 219 | $497.1M |
| Q1 2025 | 214 | $504.1M |
| Q4 2024 | 200 | $525.4M |
| Q3 2024 | 183 | $428.9M |
| Q2 2024 | 171 | $319.9M |
| Q1 2024 | 178 | $280.8M |
| Q4 2023 | 191 | $485.4M |
| Q3 2023 | 198 | $395.2M |
| Q2 2023 | 200 | $487.5M |
| Q1 2023 | 186 | $553.5M |
| Q4 2022 | 192 | $223.1M |
| Q3 2022 | 189 | $420.5M |
| Q2 2022 | 199 | $509.9M |
| Q1 2022 | 184 | $532.9M |
| Q4 2021 | 191 | $895.1M |
| Q3 2021 | 167 | $966.8M |
| Q2 2021 | 167 | $640.9M |
| Q1 2021 | 170 | $682.5M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Aurinia Pharmaceuticals Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| K2 Principal Fund, L.P. | 0 | $0 | 0.00% | −58,772−100.0% | Sold out |
| Dana Investment Advisors, Inc. | 0 | $0 | 0.00% | −50,459−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −50,200−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −40,150−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −35,484−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −29,600−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −27,338−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −25,838−100.0% | Sold out |
| Keybank National Association | 0 | $0 | 0.00% | −20,800−100.0% | Sold out |
| Weiss Multi-Strategy Advisers LLC | 0 | $0 | 0.00% | −17,922−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −17,881−100.0% | Sold out |
| Vigilare Wealth Management | 0 | $0 | 0.00% | −12,285−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −11,162−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −10,857−100.0% | Sold out |
| Gabelli & Co Investment Advisers, Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −2,370−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −349−100.0% | Sold out |
| Addison Advisors LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Professional Financial Advisors, LLC | 0 | $0 | 0.00% | −260−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −108−100.0% | Sold out |
| Kingsbury Capital Investment Advisors LLC | – | – | – | – | Not filed |
| American Portfolios Advisors | – | – | – | – | Not filed |